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Healthcare workers (HCWs) play a central role in global tuberculosis (TB) elimination efforts but
their contributions are undermined by occupational TB. HCWs have higher rates of latent and active
TB than the general population due to persistent occupational TB exposure, particularly in settings
where there is a high prevalence of undiagnosed TB in healthcare facilities and TB infection control
(TB-IC) programmes are absent or poorly implemented. Occupational health programmes in high
TB burden settings are often weak or non-existent and thus data that record the extent of the
increased risk of occupational TB globally are scarce. HCWs represent a limited resource in high TB
burden settings and occupational TB can lead to workforce attrition. Stigma plays a role in delayed
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diagnosis, poor treatment outcomes and impaired well-being in HCWs who develop TB. Ensuring
the prioritization and implementation of TB-IC interventions and occupational health programmes,
which include robust monitoring and evaluation, is critical to reduce nosocomial TB transmission to
patients and HCWs. The provision of preventive therapy for HCWs with latent TB infection (LTBI) can
also prevent progression to active TB. Unlike other patient groups, HCWs are in a unique position to
serve as agents of change to raise awareness, advocate for necessary resource allocation and
implement TB-IC interventions, with appropriate support from dedicated TB-IC officers at the
facility and national TB programme level. Students and community health workers (CHWs) must be
engaged and involved in these efforts. Nosocomial TB transmission is an urgent public health
problem and adopting rights-based approaches can be helpful. However, these efforts cannot
succeed without increased political will, supportive legal frameworks and financial investments to
support HCWs in efforts to decrease TB transmission.
R.R. Nathavitharana, P. Bond, A. Dramowski, K. Kotze, P. Lederer, I. Oxley, et al.
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Tuberculosis (TB) is now the leading cause of adult death glob-
ally from an infectious disease, surpassing HIV and malaria [1].
Moreover, TB is airborne, with the main risk activity being
breathing. Although healthcare workers (HCWs) have a central
role in global TB elimination efforts, their contributions are
undermined by the risk of occupational TB. The 2016 WHO Global
TB Report estimates that, in 2015, the number of TB cases per
100,000 HCWs was more than double the notification rate in the
general adult population [1]. The risk of TB transmission in
healthcare and other congregate settings is high [2,3] and
nosocomial outbreaks of multidrug-resistant TB (MDR-TB) and
extensively drug-resistant TB (XDR-TB) are well documented
[4,5]. TB infection control (TB-IC) is one of the key components
of the second pillar of the WHO End TB strategy [6]. However,
limited attention and resources are applied to TB-IC at both the
facility and national level, resulting in ongoing nosocomial TB
transmission [2,7]. This review will discuss some of the major
challenges and potential solutions to improve TB-IC efforts with
a focus on the role of HCWs, although it is important to empha-
size that the risks of nosocomial TB transmission also apply to
patients. We start by describing three cases that demonstrate
the current reality of occupational TB across HCW groups in high
TB burden countries (HBCs).
Case 1 – Russia
A medical student remembered finding it difficult to breathe the
first time she wore a surgical mask in the operating theatre.
Outside the theatre, the doctors who taught her did not wear
respirators and so she learnt not to do so either. The risks of
occupational TB were never discussed, although she was aware
that a medical student and a lecturer had previously fallen ill
from multidrug-resistant (MDR) TB. She remembered the shock
she felt when she received her MDR-TB diagnosis as an intern in
her hometown in Malaysia, after completing medical school in
Russia. She felt particularly lonely and struggled to come to
terms with her diagnosis. In Russia and other Eastern European
countries, HCWs have been demonstrated to be up to three
times more likely to develop TB (including MDR-TB) than thegeneral population, with the risk demonstrated to be up to 30–
90 times higher for clinicians employed in TB-specific facilities
[8].
Case 2 – South Africa
A nurse worked in a privately owned dialysis unit. She had
trained and worked in both public and private sector healthcare
facilities in South Africa throughout her career but although she
had cared for countless patients with TB, she never thought that
she herself would be at such high risk. Looking back, she noted
that the ventilation in the dialysis unit was poor with no open
windows and TB testing or existing diagnoses for patients were
never discussed. However, when she developed MDR-TB, she
was made to feel like she had done something wrong and was
very much affected by the stigma of TB. Although she is
extremely grateful to have survived occupational MDR-TB, she
developed hearing loss due to aminoglycoside therapy and has
been left with post-TB bronchiectasis, which causes frequent
exacerbations and impaired lung function. To her knowledge,
infection control practices in the dialysis unit have not changed.
A recent systematic review demonstrated high rates of latent
and active TB in South African HCWs although available data
were limited [9].
Case 3 – India
In November 2015, a senior laboratory technician at a major
hospital in Mumbai became the fourth HCW to die from MDR-TB
that year. Having diabetes put him at a higher risk of acquiring TB
and having a worse outcome from TB but it is unlikely that he
had ever received testing or treatment for latent TB. Despite
having no direct contact with patients, laboratory staff have an
increased risk of developing TB due to exposure to sputum
specimens if correct biosafety procedures including wearing
personal protective equipment (PPE) are not strictly imple-
mented. Deaths have also been noted in other non-clinical staff
including ward attendants and cleaning staff. Despite the adop-
tion of national airborne infection control guidelines in India,
site visits have demonstrated that TB-IC is frequently poorly
developed and implemented [10].tome 46 > n82 > March 2017
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The epidemiology of TB in HCWs
HCWs globally are at increased risk for TB infection and disease,
although rates of occupationally acquired TB are highest in low-
and middle-income countries (LMICs) [2,11]. In these settings,
drug-resistant TB (DR-TB) also affects HCWs at a greater fre-
quency than the communities they serve [12,13]. The increased
risk of TB affects all healthcare personnel including community
health workers (CHWs), clinical support staff, laboratory workers
and health science students [14,15]. Clinical staff (nurses and
doctors) appear to be at highest risk [16,17]. However there is a
dearth of data regarding other groups such as ancillary support
and administrative staff who may work in clinical areas and
CHWs, although at least some studies have demonstrated that
these groups are also at considerable risk [9,18–20]. Although
HCWs in LMICs may also be at high risk of TB exposure in their
communities, studies that have controlled for living conditions
confirm additional risk of TB disease attributable to workplace TB
exposure [21]. The documented 3 to 6-fold increased risk of TB is
due to persistent occupational TB exposure in the setting of
absent or poorly implemented TB-IC programmes [2,11] and a
high prevalence of undiagnosed TB in healthcare facilities
[22,23]. Ironically, accurate data on TB exposure and infection
risk in HCWs is most limited from settings with highest TB burden
[9,24]. Possible factors explaining the paucity of occupational TB
data include the lack of national HCW TB surveillance, weak or
non-existent occupational health programmes, reluctance
among HCWs to disclose a TB diagnosis owing to stigma and
the challenge of diagnosing LTBI in TB endemic settings [25]. In
some countries, the close association of TB and HIV disease
aggravates stigma surrounding a TB diagnosis, resulting in diag-
nostic and treatment delays among HCWs [25]. The risk of
occupationally acquired TB and the adverse consequences for
infected HCWs contribute to attrition of HCWs in regions already
challenged by severe shortages in human resources for health
[26,27].
TB infection control gaps
Poorly ventilated and overcrowded indoor congregate settings
where there are people with infectious but unsuspected TB, such
as healthcare facilities, may be responsible for a high proportion
of TB transmission in HBCs [3]. To address the risk of nosocomial
TB transmission, the World Health Organization (WHO) has
proposed the adoption and rigorous implementation of TB-IC
measures [28]. These guidelines divide TB-IC measures into
different types. Managerial TB-IC measures include leadership
and commitment to establish and implement infection control
policies at the health facility level [29]. Administrative control
measures include the prompt identification and separation of
persons with probable TB, emphasizing timely diagnosis and
treatment of active TB [30]. Environmental measures include
optimized operational structures, including building design andtome 46 > n82 > March 2017patient flow to decrease the concentration of airborne TB droplet
nuclei and to control the directional flow of potentially infectious
aerosols [31]. Personal protective TB-IC measures focus on the
provision of correctly fitted respirators [31]. However, even if
respirators are available, respirator fit testing is often not per-
formed and thus wearing respirators incorrectly offers a false
sense of security [32]. Additionally, respiratory protection is
typically only worn in instances where patients are being eval-
uated for known or suspected TB and therefore cannot offer
protection from transmission due to unsuspected TB [31].
Despite these clear recommendations for TB-IC, studies have
consistently demonstrated the absence of TB-IC programmes in
health-care facilities in HBCs [2,33]. The lack of implementation
and scale up of these preventative measures, with an emphasis
on rapidly diagnosing and treating unsuspected TB, are primarily
responsible for nosocomial TB transmission [10,34,35]. In HBCs
such as South Africa, poor building design, overcrowding, lack of
knowledge and training regarding facility-based IC plans and
guidelines, and poor managerial involvement in the design and
implementation of local TB-IC policy have been noted as barriers
to the implementation of such measures [36,37]. It should be
mentioned that TB-IC is also often neglected in low and medium
incidence countries. A standardized survey tool used to evaluate
drug-resistant TB management in several European countries
identified the lack of a comprehensive TB-IC plan in all the
reference centres surveyed [38]. Administrative and environ-
mental controls in particular were often lacking. Alarmingly
despite the availability of PPEs (i.e. respirators for staff and
surgical masks for patients), respirator fit testing was also not
available at any of these reference centres [32].
Lack of robust occupational health systems
Accurate surveillance and reporting of TB disease in HCWs in
LMICs is crucial to gaining a better understanding of the epide-
miology of TB in this high-risk population [39]. Although WHO
published recommendations on their global strategy of occupa-
tional health for all in 1994 [40] and released their 10-year
Global Plan of Action for Workers' Health in 2007 [41], only
31 countries have ratified the Convention on Occupational
Health Services [42] and it has been estimated that only 5 to
10% of workers in developing countries have access to adequate
occupational health services [43]. While the impact of the
2014 Ebola epidemic on the health workforce drew attention
to the lack of infection control and occupational health services
in West Africa [44], despite having a mortality rate comparable
to Ebola and causing illness in an estimated 580,000 people
annually, DR-TB has not garnered the necessary political will and
urgency to prioritize the institution and maintenance of occu-
pational health services in TB endemic countries.
Challenges with treatment and returning to work
TB treatment, particularly for drug-resistant strains, is daunting.
Outcomes for treatment of drug-resistant TB in HCWs are poor,e5
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related morbidity [12,13]. Although HCWs know the rationale
for treatment and need for adherence, many have commented
that they had little understanding of the true demands of TB and
its treatment regimens and the effect that the disease and the
antibiotics have on the body until they became patients them-
selves [45]. Consultations are often pressed for time, leaving
little or no time for compassionate conversations that delve into
the patient's emotional state or ability to cope with treatment
[27]. For HCWs such as CHWs or ancillary staff, as well as foreign
HCWs, there may also be language, cultural or educational
barriers that affect crucial knowledge transfer. Social support
networks may be limited. Side effects such as peripheral neu-
ropathy, ototoxicity and vision loss may be career-ending for
HCWs [27,45,46]. Although HCWs may have better access to
healthcare facilities than other patients, they may encounter
greater stigma and be reluctant to engage in care [47]. This also
has implications for their ability to return to work. The psycho-
logical and financial costs of not being able to return to work
may be crippling for HCWs and their families.
Per guidelines from the U.S. Centers for Disease Control, HCWs
with TB should be allowed to return to work when they:
 have had three negative AFB sputum smear results collected
8–24 hours apart (at least one of which should be an early
morning specimen); have responded to anti-TB treatment that should be effective
based on drug susceptibility testing results [48].
The assessment of whether a HCW with TB is no longer infec-
tious and can return to work should be made by a physician who
has expertise in the management of TB. Notably, HCWs in HBCs
are often reluctant to return to healthcare facilities, where they
risk re-exposure and reinfection [27].
Stigma and occupational TB
Despite romanticized perceptions regarding 'consumption' in
Victorian times, the language that has subsequently been used
within the TB community has undoubtedly contributed to the
stigma associated with this preventable and curable disease.
Terms such as 'TB suspect' and 'default' have criminal connota-
tions [49] and there has been an increasing emphasis on avoid-
ing the use of such stigmatizing terminology. Goffman's
definition of stigma [50] was reworked and applied to HIV by
Alonzo and Reynolds [51] who described stigma as being a
'powerful discrediting and tainting social label that radically
changes the way individuals view themselves and are viewed
as persons.' This definition also introduces the concepts of
external and internal stigma.
External stigma is directed towards HCWs by other HCWs. Accord-
ing to Courtwright et al., the commonest cause of stigma is the
perceived risk of transmission [52]. HCWs diagnosed with TB are
excluded or avoided, often long after the initial high-risk period
for transmission. TB is also stigmatized because of itsconnotations with malnutrition, poverty and HIV, which may
prompt open speculation in the workplace about the affected
healthcare worker's immune status [53,54].
Internal stigma is directed by HCWs towards themselves. Feel-
ings of isolation and shame associated with TB can lead to
withdrawal from the community. One of the symbols of the
contagious nature of TB, and hence also the stigma associated
with it, is the mask. Interestingly, although masks are worn
routinely in some clinical environments like the operating the-
atre and in certain countries when using public transport,
patients wearing masks to reduce TB transmission report feeling
stigmatized and HCWs wearing respirators for protection find
that this creates a barrier between them and their patients
[47,55].
There is a need to refine existing TB stigma scales developed for
HCWs and measure the impact of various strategies to reduce
stigma [56]. Possible interventions include bringing affected
HCWs together to support each other [52] or large-scale com-
munity-based campaigns like the Unmask Stigma campaign that
has taken place on World TB day [57,58]. Addressing stigma
could have a positive impact on diagnostic delays, treatment
outcomes, psychological well-being and awareness about the
prevalence of occupational TB.
Solutions
TB infection control solutions
The primary aim of the WHO checklist for periodic evaluation of
TB-IC in health-care facilities is to prevent the transmission of TB
to both patients and HCWs [59]. From a management perspec-
tive, a TB-IC plan that includes a person responsible for TB-IC and
an adequate budget for TB-IC activities such as training should
be available at all health facilities. In addition, all staff should
receive TB-IC training at least every two years as recommended
by the WHO [59]. Each facility should have administrative IC
measures in place, such as FAST (Find cases Actively using cough
screening and rapid molecular diagnostics, Separate temporarily
and promptly Treat effectively) [30] and environmental control
measures such as improving ventilation, decreasing overcrowd-
ing and the use of germicidal ultraviolet disinfection [3,31].
These measures should be considered at the outset during
the health facility planning process and IC officers should thus
be part of advisory committees to architects designing health
facilities to give input on TB-IC measures. Although it is essential
that HCWs as well as ancillary staff working in patient-care areas
should have access to N95 respirators that fit them correctly, this
should not preclude concurrent implementation of administra-
tive TB-IC controls [60]. Staff shortages and inadequate training
at facilities where TB is treated should be addressed [37].
Regular training on TB-IC along with monitoring of HCWs' and
institutional adherence to these measures should occur, so that
areas with poor adherence can be identified and remediated.
Implementing a comprehensive TB-IC package may seemtome 46 > n82 > March 2017
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and setting-specific context is important. For example, maxi-
mizing natural ventilation will be feasible in healthcare facilities
in warmer climates but in colder climates, interventions such as
germicidal ultraviolet air disinfection may yield greater benefits
[31]. Establishing reporting systems through which HCWs can
document TB-IC implementation issues that would require
attention at the facility and subsequently failing that, at the
NTP level, could help to bridge the gap between TB-IC policy and
practice.
Developing and strengthening occupational health
systems
Occupational health programmes should be prioritized, main-
tained and rigorously evaluated, with an emphasis on electronic
data collection to facilitate operational monitoring and evalua-
tion [61]. We advocate that occupation should be added to
facility TB patient registers and recorded by national TB pro-
grammes so that the epidemiology of occupational TB can be
better understood and enable the prioritization of target inter-
ventions [39]. Regular occupational screening for TB should be
available at each health facility. This involves overcoming chal-
lenges such as shortages of tuberculin for skin testing or the
costs of interferon gamma release assay testing, both of which
are used for the diagnosis of latent TB. Occupational health
programmes in TB endemic settings should also offer HIV testing
and linkage to care, which should at minimum include the
provision of isoniazid preventive therapy (IPT) for HCWs with
HIV. The feasibility of relocating HCWs living with HIV to a lower
risk clinical area [28] is contentious since the majority of clinical
areas in HBCs pose a TB transmission risk due to the high
prevalence of undiagnosed TB.
HCWs (regardless of HIV status) in many low prevalence settings
have access to treatment for LTBI, an intervention proven over
decades to be effective [62–64]. HCWs in high-burden settings
should therefore also have an opportunity to prevent their
progression from infection to disease through the provision of
LTBI therapy, since the risk of progression is higher in high
transmission settings. The lack of LTBI treatment for high-risk
groups such as HCWS represents not only an important gap in TB
control efforts but also one that is within the power of the
current healthcare system itself to remediate. Access to rapid
molecular diagnostic tests such as Xpert MTB/RIF for active TB
diagnosis [65] must be ensured so that healthcare professionals
can be promptly tested if they experience any symptoms of TB
and start effective therapy based on drug susceptibility testing
[28]. Confidentiality should be ensured as far as possible with
regard to the outcome of tests, to overcome this barrier to
getting tested [61], although it is important that this should
not preclude contact screening. Building robust occupational
health systems will be an important component for overall
TB elimination efforts [42].tome 46 > n82 > March 2017How can HCWs be agents of change?
HCWs should advocate for the adoption of policies aimed at
documenting, preventing and addressing nosocomial TB trans-
mission. HCWs are in a unique situation, compared to other
populations who are particularly vulnerable to TB, as they may
be able to have greater input into developing and implementing
such policies to protect not only themselves but also their
patients [39]. Although health advocacy has not always been
an explicitly expected role for HCWs to fulfill, and while many
HCWs may view their area of expertise and responsibility as
clinical, the importance of advocacy was stressed in a commis-
sion on global health professional education published in The
Lancet in 2010 [66] and as part of the CanMEDS framework for
physician competency [67].
One approach designed to engage HCWs to become agents of
change has focused on sharing relatable stories of HCWs
affected by tuberculosis to destigmatize occupational TB and
dispel the notion that HCWs are "TB Proof'', highlighting the
shared risk in healthcare facilities [45]. HCWs can also advocate
for testing and treatment for LTBI, which has been a neglected
issue in HBCs but is now the subject of greater attention. The
HCWs described in Cases 1 and 2 were both successfully treated
for MDR-TB and are now staunch advocates for HCW workplace
safety focused on TB prevention and destigmatization and are
working with other agents of change to raise awareness and
mobilise the wider HCW community.
The importance of educating and engaging
healthcare students
Students training to become health professionals are exposed to
the same occupational hazards as their professional counter-
parts and resultantly have a high risk of occupational TB [68].
Although students in endemic settings may report perceiving
themselves to be at higher risk of TB and are more likely to have
received TB-IC training than other HCWs [69], they are not more
likely to provide correct examples of TB-IC measures or to use
PPE as recommended [70,71]. Additionally, it is concerning to
note that healthcare students have indicated that they perceive
their professional mentors to be similarly aware of the risks of
occupational tuberculosis, but report that they do not take the
necessary precautions [47,69]. Many professional behaviours
are modeled on those of mentors [72], and efforts need to be
made to ensure that safe practices are emphasized in order to
form a foundation for future practices. Engaging future HCWs
during this early stage of their training by focusing some inter-
vention efforts on large hospitals that serve as teaching sites can
help to facilitate HCWs becoming and remaining agents of
change (ﬁgure 1).
Human rights and the role of the law
Legal and regulatory frameworks have a role to play in decreas-
ing TB transmission [73]. There have been scant efforts in
highlighting the role and importance of human rights in globale5
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Figure 1
TB Proof awareness and advocacy session, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
Picture credit: TB Proof.
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tation of TB-specific legislation, which can articulate the rights of
people with TB, the risk of TB in nosocomial settings and the
harms of stigma and discrimination, in TB endemic countries
[74].
With regards to TB-IC, the global health community lacks a sound
understanding of the law's effect on population health.
Although the existence of laws and regulations does not ensure
that they will be implemented, they provide a structural frame-
work to guide TB-IC efforts. Consequently, a better understand-
ing of the existing laws that address TB-IC is a prerequisite to
assessing their implementation and their effect on practice. A
review of laws and regulations described and analysed legisla-
tive approaches to TB-IC practices in Botswana, South Africa and
Zambia, focusing on selected elements of WHO's TB-IC policy
[75]. In all three countries, TB case reporting is required, as is TB
surveillance among HCWs. Each country's legal and regulatory
framework also addresses the need to respect individuals' rights
and privacy while safeguarding public health. Although these
laws and regulations should create a strong foundation for TB-IC,
poor TB-IC implementation [2] and scant data on occupational TBfrom LMICs such as these [9] suggests otherwise. Future
research should assess the implementation and public health
impact of laws and regulations regarding TB-IC.
Laws such as the Occupational Health and Safety Act (OHSA) in
South Africa [76] classify TB as an occupational disease, which
means that HCWs who develop TB should receive compensation,
including occupational sick leave, medical expenses, permanent
disability payments and payments to surviving family members.
Unfortunately students, CHWs and volunteers with the same
exposures typically do not receive the same legal protection
despite suffering the same devastating consequences [45].
Legal frameworks must be strengthened to ensure that TB-IC
measures are implemented, monitored and evaluated as rec-
ommended and to provide care and compensation to all HCWs
including trainees and volunteers who are affected by occupa-
tional TB. This is an ethical imperative for policy makers [77].
Ongoing scientific challenges
It is estimated that 1.7 billion people globally are infected with
TB [78]. Certain risk factors that increase the likelihood of
developing active TB have been identified such as HIV, diabetestome 46 > n82 > March 2017
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HCWs, who are more likely to have LTBI than the general
population [24], it is not possible to predict who will develop
active TB. IPT or alternative LTBI treatment regimens have been
recommended in high and low-incidence settings for groups at
high risk of TB reactivation, such as people living with HIV and
contacts of patients with pulmonary TB [79]. However, there is
currently no guidance for HIV-uninfected HCWs (or other HIV-
uninfected individuals) in HBCs who are at frequent risk of re-
exposure and re-infection [80]. This is the subject of debate but
based on evidence that treatment of LTBI decreases the risk of
future reactivation to TB disease [62–64] resulting in this being a
policy recommendation for low-incidence countries [81], pre-
ventive therapy should be recommended and available for
HCWs as well as others in HBCs with TB infection despite their
re-exposure and re-infection risk. Due to the increasing inci-
dence of MDR- and XDR-TB, there are increasing numbers of
people (including HCWs) with latent DR-TB, but there are no
guidelines regarding preventive therapy for DR-TB exposure.
Although HCWs in HBCs will typically have received the Myco-
bacterium bovis Bacille Calmette-Guérin (BCG) vaccine as part ofTABLE I
Suggested action points
Level of health system Suggested actions
Local facility Establish a TB-IC plan in accordance with WHO
Provide training to and support for dedicated 
Develop peer education sessions that may be
Implement Occupational Health Programmes 
active TB disease and providing treatment for
be assured wherever possible but not preclud
Occupation should be recorded on TB registry
Identify high-risk areas that are poorly ventila
implementing strategies such as mechanical v
Ensure that fit-tested respirators are available
National TB programme Ensure robust M&E programmes for TB-IC and
Include community health workers, at-risk no
they receive adequate training
Institute and utilize supportive legal framewo
Ensure access to diagnostic testing and treatm
WHO Record annual numbers of HCWs that develop
include occupation as an indicator
Provide guidance regarding legal frameworks
Provide guidance regarding preventive therap
to DR-TB
tome 46 > n82 > March 2017the childhood immunization series, the effectiveness of this
vaccine is primarily to reduce the risk of TB meningitis in infants.
Data suggests that BCG also reduces the risk of infection [82], but
BCG immunity subsequently wanes over time, such that vacci-
nation does not prevent adults from developing TB [83]. Due to
the complex biology of Mycobacterium tuberculosis, multiple
vaccine strategies are being pursued to:
 c
TB
 s
th
 b
e 
 fo
te
e
 fo
 O
n-
rk
e
 T
 to
y prevent TB infection after initial exposure;
 prevent the development of TB disease in those who are
infected but asymptomatic; to prevent recurrent disease in those who have developed and
been treated for TB disease [84].
Conclusions
TB elimination efforts cannot succeed without increased atten-
tion and resources being channeled towards TB-IC and occupa-
tional health systems strengthening. Table I demonstrates
suggested action points at the individual healthcare facility,
National TB Programme and supranational WHO level that are
critical to decrease nosocomial TB transmission, which includes
occupational TB. A focus on monitoring and evaluating TB-IChecklist guidelines with regular monitoring and evaluation (M&E)
-IC officers
trengthened by advocacy from occupational TB survivors
at include testing HCWs for development of latent TB infection and
oth, along with linkage to HIV testing and care. Confidentiality should
contact evaluation
rms
d or overcrowded for mitigation by changing patient flow and/or
ntilation and/or germicidal ultraviolet air disinfection
r all staff working in clinical areas, including students
ccupational Health Programmes
clinical hospital staff and students in these programmes and ensure that
s to ensure that TB-IC implementation occurs along with requisite M&E
nt for latent and active TB
B infection and disease based on facility case records that should
 support TB-IC and occupational health programmes
for HIV-uninfected HCWs, including those who may have been exposed
e5
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ments are being made. HCWs are uniquely placed as agents of
change to raise awareness and decrease stigma regarding
occupational TB, advocate for policies supported by legislation
and critically to act by implementing the solutions discussed in
this review. This can lead to healthcare facilities becoming safer
for both HCWs and the patients they serve and enabling the
delivery of high quality care, even in under-resourced high TB
burden countries. Strong leadership coupled with sustained
political commitment, supportive legislative frameworks andReferences
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